정부/공공기관
임상시험센터
CRO
분석CRO/센트럴랩
유관기관/협회
정보서비스
해외 유관 기관
* CRO 게재 기준: CRO자율등록 기관
ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2550건이 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 534 | Not yet recruiting | Selenium as a Potential Treatment for Moderately-ill, Severely-ill, and Critically-ill COVID-19 Patients. | Covid19 | Drug: Selenium (as Selenious Acid) Other: Placebo |
Phase 2 | CHRISTUS Health, Pharco Pharmaceuticals | OTHER | 100 | All | 18 Years | CHRISTUS Good Shepherd Medical Center, Longview, Texas, United States |
| 533 | Not yet recruiting | Semaglutide to Reduce Myocardial Injury in PATIents With COVID-19 | Myocardial Injury | Drug: semaglutide | Phase 2 | Vladimir D?avik, Unity Health Toronto, Canadian Institutes of Health Research (CIHR), University of Toronto | OTHER | 400 | All | 18 Years | Instituto Prevent Senior, Sao Paulo, Brazil State University of Campinas, Sao Paulo, Brazil Trillium Health Partners, Mississauga, Ontario, Canada St. Michael's Hospital, Toronto, Ontario, Canada University Health Network - Peter Munk Cardiac Centre, Toronto, Ontario, Canada McGill University Health Centre, Montreal, Quebec, Canada Hospital de Infectologia, Mexico City, Mexico Hospital General Regional, Mexico City, Mexico Hospital Regional 2, Queretaro, Mexico Sandwell and West Birmingham NHS Trust, Birmingham, United Kingdom |
| 532 | Recruiting | Senicapoc in COVID-19 Patients With Severe Respiratory Insufficiency | COVID | Drug: Senicapoc | Phase 2 | University of Aarhus, Aarhus University Hospital, Odense University Hospital, Aalborg University Hospital, Hvidovre University Hospital | OTHER | 46 | All | 18 Years | Aalborg University Hospital, Aalborg, Denmark Aarhus University Hospital, Aarhus, Denmark Hvidovre Hospital, Hvidovre, Denmark Odense University Hospital, Odense, Denmark |
| 531 | Recruiting | SeroCOVIDial Study: Assessment of COVID-19 Seroconversion in Patients on Chronic Hemodialysis and in Their Caregivers, a Cohort Study | Caregivers of Chronic Hemodialysis Patients | Biological: Blood sample Biological: Serum tube collection |
Not Applicable | Assistance Publique Hopitaux De Marseille | OTHER | 800 | All | 18 Years | Assistance Publique Hopitaux de Marseille, Marseille, Paca, France |
| 530 | Completed | Serology COVID-19 From the Cornwall Hospital Union | Corona Virus Infection | Biological: Serological test Biological: Serum test |
Not Applicable | Centre Hospitalier de Cornouaille, Centre Hospitalier Regional et Universitaire de Brest | OTHER | 2587 | All | 18 Years | CH de Cornouaille, Quimper, France |
| 529 | Completed | Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19) | Covid19 | Drug: BGB-DXP593 Drug: Placebo |
Phase 2 | BeiGene | INDUSTRY | 181 | All | 18 Years ~ 65 Years | Elixia, Hollywood, California, United States Midland Florida Clinical Research Center, LLC, DeLand, Florida, United States Baptist Medical Center, Jacksonville, Florida, United States Homestead Associates in Research Inc., Miami, Florida, United States Medical Research Center of Miami II, Inc., Miami, Florida, United States US Associates in Research, Miami, Florida, United States Continental Research Network, Miami, Florida, United States Omega Research Orlando, Orlando, Florida, United States Revival Research Institute, LLC., Dearborn, Michigan, United States New Phase Research & Development, Knoxville, Tennessee, United States Amarillo Center for Clinical Research, Amarillo, Texas, United States PanAmerican Clinical Research, Brownsville, Texas, United States The Royal Prince Alfred Hospital, Camperdown, Australia Fundacao Universidade de Caxias do Sul - Instituto de Pesquisas em Saude, Petropolis, Caxias Do Sul, Brazil Hospital das Clinicas da Faculdade de Medicina de Botucatu, Botucatu, Brazil Irmandade da Santa Casa de Misericordia de Porto Alegre, Porto Alegre, Brazil Hospital Universitaro de Santa Maria / UFSM, Santa Maria, Brazil CMPC Pesquisa Clinica, Sorocaba, Brazil Hospital Cardiologica Aguascalientes, Aguascalientes, Mexico JM Research, Cuernavaca, Mexico Hospital General Dr. Manuel Gea Gonzalez, Mexico, Mexico Iecsi S.C., Monterrey, Mexico Clinica de Enfermedades Cronicas y de Procedimientos Especiales, S.C., Morelia, Mexico Kohler & Milstein Research, Merida, Mexico PanAmerican Clinical Research, Queretaro, Mexico East Rand Research T/A Worthwhile Clinical Trials, Benoni, South Africa TASK, Cape Town, South Africa TREAD Research CC, Cape Town, South Africa Langeberg Clinical Trials, Cape Town, South Africa Wits Clinical Research, Soweto, South Africa |
| 528 | Completed | Sevoflurane in COVID-19 ARDS (SevCov) | Coronavirus | Drug: Sevoflurane Drug: Intravenous drug |
Phase 3 | University of Zurich, Kantonsspital Munsterlingen, Triemli Hospital, Cantonal Hospital of St. Gallen | OTHER | 68 | All | 18 Years ~ 85 Years | Kantonsspital Munsterlingen, Munsterlingen, Switzerland Cantonal Hospital of St. Gallen, Sankt Gallen, Switzerland Stadtspital Triemli, Zurich, Switzerland University Hospital Zuirch, Zurich, Switzerland |
